1628618-33-6

Basic information

• Product Name: 7-chloro-5-methyl-2-(2-(quinolin-2-yl)ethyl)-2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-1,6(5H)-dione
• Synonyms: 7-chloro-5-methyl-2-(2-(quinolin-2-yl)ethyl)-2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-1,6(5H)-dione;1H-Pyrrolo[3,4-c]pyridine-1,6(2H)-dione, 7-chloro-3,5-dihydro-5-methyl-2-[2-(2-quinolinyl)ethyl]-
• CAS NO: 1628618-33-6
• Molecular Formula: C19H16ClN3O2
• Molecular Weight: 353.80224
• Mol File: 1628618-33-6.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 7-chloro-5-methyl-2-(2-(quinolin-2-yl)ethyl)-2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-1,6(5H)-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 7-chloro-5-methyl-2-(2-(quinolin-2-yl)ethyl)-2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-1,6(5H)-dione(1628618-33-6)
• EPA Substance Registry System: 7-chloro-5-methyl-2-(2-(quinolin-2-yl)ethyl)-2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-1,6(5H)-dione(1628618-33-6)

Safety Data

• Hazardous Substances Data: 1628618-33-6(Hazardous Substances Data)

Upstream product

• 2005-43-8 2-bromoquinoline 
• 5100-57-2 ethyl 2-(2-quinolyl)acetate 
• 130879-33-3 dimethyl 5-chloro-1-methyl-6-oxo-1,6-dihydropyridine-3,4-dicarboxylate 
• 14068-28-1 2-(quinolin-2-yl)acetonitrile 
• 4377-41-7 2-Chloromethylquinoline 
• 104037-38-9 D 1997 
• 74273-98-6 N-<2-(2-Quinolyl)ethyl>succinimide 
• 1011-50-3 2-quinolin-2-yl-ethanol 

Relevant articles and documents

NOVEL INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A

The present invention relates to compounds of the formula (I), the N-oxides, tautomers, the prodrugs and the pharmaceutically acceptable salts thereof. In formula I the variables Het, A, X, Y, Z, R1, R2, R3, R4, R5 and Q are as defined in the claims. The compounds of the formula I, the N-oxides, tautomers, the prodrugs and the pharmaceutically acceptable salts thereof are inhibitors of phosphodiesterase type 10A. Thus, the invention also relates to the use of the compounds of the formula I, the N-oxides, tautomers, the prodrugs and the pharmaceutically acceptable salts thereof for the manufacture of a medicament and which thus are suitable for treating or controlling of medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders.